Lupin Limited
NSE: LUPIN | Information Technology
Market Fundamentals
Stock Intelligence & News
Lupin Ltd (500257)
Lupin Announces Approval from U.S. FDA for Pitolisant Tablets.
Read Full Analysis →Lupin Limited
Lupin Limited has informed the Exchange regarding a press release dated August 17, 2026, titled "Lupin Announces Approval from U.S. FDA for Pitolisant Tablets". |SUBJECT: Press Release
Read Full Analysis →Natco Pharma Limited
Natco Pharma Limited has informed the Exchange regarding a press release dated Jun 03, 2026, titled "NATCO Pharma Limited and Lupin Limited receive approval from U.S. FDA for Eribulin Mesylate Injection". |SUBJECT: Press Release
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Get instant alerts when LUPIN breaks news
Join investors who track Lupin Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for LUPIN?
LUPIN is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for Lupin Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding LUPIN to your custom watchlist.